GTC Biotherapeutics (fka GTCB)

[DewDiligence]

>…Margret Destrempes, Stephen Blash, David Melican, William Gavin, Yann Echelard and Susan Overton of GTC Biotherapeutics Inc.<

Thanks, genisi! I wonder how far into the future the commercialization of this technique might be. For now, GTC seems to be committed to the nuclear-transfer method licensed from Geron.

By the way, Yann Echelard spoke at the annual shareholders’ meeting and is GTC’s “point man” on rFVIIa. Regards, Dew